Topics

High-grade gliomas | Treatment | Targeted therapy | Nilotinib

Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Nilotinib

Piccioni D, Juarez TM, Kesari SL, Rose L, Nomura N, Kesari S.
Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomas.
Neurooncol Adv. 2025 Jul 10;7(1):vdaf150. doi: 10.1093/noajnl/vdaf150. PMID: 40709015. Interventional study. ˍ